Five Prime Therapeutics Secures $40,282,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6b9da21-32df-4100-bde7-902482a1fb12&Preview=1 -
Date
6/30/2008 -
Company Name
Five Prime Therapeutics -
Mailing Address
1650 Owens Street San Francisco, CA 94158 -
Company Description
FivePrime is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) – the entire set of pharmaceutically relevant genes and proteins. -
Website
http://www.fiveprime.com -
Transaction Type
Venture Equity -
Transaction Amount
$40,282,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Advanced Technology Ventures -
Venture Investor
Domain Associates -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
Healthcap Venture Capital -
Venture Investor
Versant Ventures
